Dyer Timothy Mark
SEC CIK 1830908 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADXN | Addex Therapeutics Ltd. | CEO, Dir | 435.2K | — | — | 2 | 2026-09-02 | 2026-09-02 |
Most active insiders at ADXN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kalinichev Mikhail | HEAD OF TRANSLATIONAL SCIENCE | — | — |
| 2 | Lawton Vincent Michael | Dir | — | — |
| 3 | Hill Raymond George | Dir | — | — |
| 4 | Dyer Timothy Mark | CEO, Dir | — | — |
| 5 | Manke Isaac | Dir | — | — |
| 6 | Nunn Jason Raleigh | Dir | — | — |
| 7 | Mills Roger | Chief MEDICAL Off, Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-04 16:00 | 2026-09-02 | ADXN | Addex Therapeutics Ltd. | Dyer Timothy Mark | CEO, Dir | D - Sale to Iss | $0.00 | -16.41M | 435.2K | -97% | $0 |
| D | 2026-09-04 16:00 | 2026-09-02 | ADXN | Addex Therapeutics Ltd. | Dyer Timothy Mark | CEO, Dir | A - Grant | $0.00 | +16.41M | 16.85M | +3,772% | $0 |
Purchase Sale Sale after option exercise All abbreviations